诺和诺德全球概述：
诺和诺德公司是一家致力于人类健康、以先进的生物技术造福患者、医生和社会的世界领先生物制药公司。诺和诺德公司在行业内拥有最为广泛的糖尿病治疗产品，其中包括最先进的胰岛素给药系统产品。诺和诺德公司的历史最早可追溯至 1923 年， 80 多年来一直是糖尿病研究和药物开发领域的主导。诺和诺德总部位于丹麦首都哥本哈根，现今在全球 79 个国家设有分支机构， 6 个国家设有生产厂，员工超过 22000 名，销售遍及 180 个国家。

主要治疗领域：
诺和诺德凭借自身的研发实力成为世界糖尿病治疗领域先导，在行业内拥有最为广泛的糖尿病治疗产品，其中包括最先进的胰岛素给药系统产品。除此之外，诺和诺德还在止血管理、生长保健激素以及激素替代疗法等医疗领域居世界领先地位。

About Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark , Novo Nordisk has production facilities in 6 countries, employs more than 22,000 full-time employees in 79 countries, and markets its products in 180 countries.

Major Therapeutic Areas
Novo Nordisk is a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.